Mortgage insurer Enact's Q2 revenue edges past estimates
ACT•Key details
| Metric | Beat/Miss | Actual | Consensus Estimate |
| Q2 Revenue | Slight Beat* | $317.31 mln | $315.81 mln (3 Analysts) |
| Q2 Adj. Diluted Operating Income per share | Beat | $1.26 | $1.19 (5 Analysts) |
| Q2 EPS | $1.25 | ||
| Q2 Net Income | $175 mln | ||
| Q2 Adjusted Operating Income | $177 mln | ||
| Q2 Expense Ratio | 21% | ||
| Q2 ROE | 13% |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst coverage
- The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
- The average consensus recommendation for the property & casualty insurance peer group is "buy."
- Wall Street's median 12-month price target for Enact Holdings Inc is $45.00, about 6% below its August 4 closing price of $47.89
- The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 9 three months ago
Capital return and outlook
- Company repurchased 2.2 mln shares for $93 mln and raised capital return guidance
- Enact raises 2026 capital return guidance to $550 mln-$600 mln, up from prior outlook
